ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,005Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 87

$990K Total Retail Price of All Prescriptions

Rank: 3 out of 87

829 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 829 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

4% of this provider’s 829 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 8,601 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$99 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
CLOPIDOGREL 662 610 1 6
FUROSEMIDE 603 562 2 8
PLAVIX 508 452 3 12
CRESTOR 480 394 4 14
METOPROLOL TARTRATE 446 401 5 2
CARVEDILOL 445 360 6 4
ATORVASTATIN CALCIUM 431 349 7 11
LISINOPRIL 250 221 8 3
AMLODIPINE BESYLATE 237 217 9 9
BYSTOLIC 226 203 10 31
SIMVASTATIN 200 184 11 5
DIGOXIN 194 162 12 13
NITROSTAT 185 167 13 19
EFFIENT 183 146 14 39
HYDROCODONE-ACETAMINOPHEN 180 132 S3 15 35
ENALAPRIL MALEATE 167 126 16 29
NITROGLYCERIN PATCH 166 149 17 30
METOPROLOL SUCCINATE 163 127 18 1
ISOSORBIDE MONONITRATE ER 145 132 19 10
ZETIA 134 120 20 27
ATENOLOL 127 108 21 15
KLOR-CON M20 122 95 22 38
LEVOTHYROXINE SODIUM 117 106 23 24
VYTORIN 114 106 24 58
PRAVASTATIN SODIUM 113 108 25 18
LOSARTAN POTASSIUM 112 102 26 16
PRADAXA 105 102 27 20
WARFARIN SODIUM 104 88 28 7
NIASPAN 103 91 29 34
OMEPRAZOLE 95 71 30 26
TRICOR 89 73 31 51
ZOLPIDEM TARTRATE 88 57 32 61
POTASSIUM CHLORIDE 86 67 33 17
CLONIDINE HCL 82 80 34 46
LOSARTAN-HYDROCHLOROTHIAZIDE 82 82 34 54
SPIRONOLACTONE 77 53 36 22
BENICAR 74 65 37 69
DIOVAN 69 53 38 37
NEXIUM 69 44 38 50
COUMADIN 64 52 40 44
FENOFIBRATE 61 56 41 47
AMIODARONE HCL 58 58 42 25
RAMIPRIL 56 52 43 28
LIPITOR 56 47 43 59
HYDROCHLOROTHIAZIDE 52 34 45 21
WELCHOL 50 50 46 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.